{"title":"[Identification of Rare 3.5 kb Deletion in the β-Globin Gene Cluster].","authors":"Yun-Hua Fan, Cui-Lin Duan, Sai-Li Luo, Shi-Jun Ge, Chong-Fei Yu, Jue-Min Xi, Jia-You Chu, Zhao-Qing Yang","doi":"10.19746/j.cnki.issn.1009-2137.2025.01.025","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To identify the gene mutation types of 4 suspected β-thalassemia patients in Yunnan Province, and to analyze the genotypes and hematological phenotypes.</p><p><strong>Methods: </strong>Whole genome sequencing was performed on the samples of 4 suspected β-thalassemia patients from the Dai ethnic group in a thalassemia endemic area of Yunnan Province, whose hematological phenotypes were not consistent with the results of common thalassemia gene mutations. The mutations of β-globin gene clusters were confirmed by polymerase chain reaction (PCR) and Sanger DNA sequencing technology.</p><p><strong>Results: </strong>The 3.5 kb deletion in β-globin gene cluster (NC_000011.10: g. 5224302-5227791del3490bp) was detected in 4 patients' samples, of which 1 case was also detected with HbE mutation and 1 case with CD17 mutation. These 2 patients displayed moderate anemia phenotype, while the two patients with only the 3.5 kb deletion presented with other mild anemia phenotype.</p><p><strong>Conclusion: </strong>Heterozygous carriers with rare 3.5 kb deletion of the β-globin gene cluster may develop mild anemia, compound mutations of the 3.5 kb deletion with other mutations may led to intermediate thalasemia with moderate to sever anemia. In areas with a high incidence of thalassemia, suspected patients should undergo genetic testing to avoid missing or misdiagnosing rare mutations.</p>","PeriodicalId":35777,"journal":{"name":"中国实验血液学杂志","volume":"33 1","pages":"175-179"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国实验血液学杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.19746/j.cnki.issn.1009-2137.2025.01.025","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
目的确定云南省 4 例疑似β-地中海贫血患者的基因突变类型,并分析其基因型和血液学表型:方法:对云南省地中海贫血流行区傣族的4例疑似β地中海贫血患者的血液学表型与常见地中海贫血基因突变结果不一致的样本进行全基因组测序。通过聚合酶链式反应(PCR)和 Sanger DNA 测序技术确认了β-球蛋白基因簇的突变:结果:在4例患者样本中检测到β-球蛋白基因簇3.5 kb缺失(NC_000011.10: g. 5224302-5227791del3490bp),其中1例检测到HbE基因突变,1例检测到CD17基因突变。这两名患者表现为中度贫血,而仅有 3.5 kb 缺失的两名患者则表现为其他轻度贫血:结论:β-球蛋白基因簇罕见的 3.5 kb 缺失的杂合子携带者可能会出现轻度贫血,3.5 kb 缺失与其他突变的复合突变可能会导致中度至重度贫血的中间型地中海贫血症。在地中海贫血症高发地区,疑似患者应进行基因检测,以避免漏诊或误诊罕见突变。
[Identification of Rare 3.5 kb Deletion in the β-Globin Gene Cluster].
Objective: To identify the gene mutation types of 4 suspected β-thalassemia patients in Yunnan Province, and to analyze the genotypes and hematological phenotypes.
Methods: Whole genome sequencing was performed on the samples of 4 suspected β-thalassemia patients from the Dai ethnic group in a thalassemia endemic area of Yunnan Province, whose hematological phenotypes were not consistent with the results of common thalassemia gene mutations. The mutations of β-globin gene clusters were confirmed by polymerase chain reaction (PCR) and Sanger DNA sequencing technology.
Results: The 3.5 kb deletion in β-globin gene cluster (NC_000011.10: g. 5224302-5227791del3490bp) was detected in 4 patients' samples, of which 1 case was also detected with HbE mutation and 1 case with CD17 mutation. These 2 patients displayed moderate anemia phenotype, while the two patients with only the 3.5 kb deletion presented with other mild anemia phenotype.
Conclusion: Heterozygous carriers with rare 3.5 kb deletion of the β-globin gene cluster may develop mild anemia, compound mutations of the 3.5 kb deletion with other mutations may led to intermediate thalasemia with moderate to sever anemia. In areas with a high incidence of thalassemia, suspected patients should undergo genetic testing to avoid missing or misdiagnosing rare mutations.